MicroRNA-96 Promotes Tumor Invasion in Colorectal Cancer via RECK

Anticancer Res. 2018 Apr;38(4):2031-2035. doi: 10.21873/anticanres.12442.

Abstract

Background: miR-96 is reported to inhibit reversion cysteine-rich Kazal motif (RECK), which is associated with tumor invasion, in solid cancer types (e.g. breast cancer, non-small cell lung cancer, esophageal cancer). The purpose of this study is to clarify whether miR-96 is similarly associated with tumor invasion in colorectal cancer.

Materials and methods: We performed western blotting to investigate the expression of RECK when miR-96 mimics or inhibitors were transferred into HCT-116 colorectal cancer cells. The RECK mRNA level was assessed by a reverse transcription polymerase chain reaction. An invasion assay was used to evaluate tumor invasion.

Results: The expression of RECK was inhibited by the transfection of miR-96 mimics. RECK mRNA level was reduced by miR-96 mimics and increased by miR-96 inhibitor. In the invasion assay, miR-96 mimics were shown to promote tumor invasion.

Conclusion: miR-96 may be associated with tumor invasion through inhibition of RECK expression in colorectal cancer.

Keywords: MiR-96; MicroRNA; RECK; cell invasion; colorectal cancer.

MeSH terms

  • Biomimetic Materials / administration & dosage
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / metabolism
  • Colorectal Neoplasms / pathology*
  • Colorectal Neoplasms / therapy
  • GPI-Linked Proteins / antagonists & inhibitors*
  • GPI-Linked Proteins / biosynthesis
  • GPI-Linked Proteins / genetics
  • HCT116 Cells
  • Humans
  • MicroRNAs / administration & dosage
  • MicroRNAs / genetics*
  • Neoplasm Invasiveness
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Transfection
  • Up-Regulation

Substances

  • GPI-Linked Proteins
  • MIRN96 microRNA, human
  • MicroRNAs
  • RECK protein, human
  • RNA, Messenger